United Therapeutics Corporation To Present At 33rd Annual J.P. Morgan Healthcare Conference

SILVER SPRING, Md., Jan. 6, 2015 /PRNewswire/ -- United Therapeutics Corporation UTHR announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, and Roger Jeffs, Ph.D., President and Co-Chief Executive Officer, of United Therapeutics will provide an overview and update on the company's business at the 33^rd Annual J.P. Morgan Healthcare Conference in San Francisco, California.

The presentation and the immediately following Q&A breakout session will take place on Monday, January 12, 2015, at 4:00 PM Pacific Standard Time, and can be accessed via a live webcast on the United Therapeutics website at http://www.unither.com under the "Investor" tab in the "Events and Presentations" section. An archived, recorded version of the presentation and the Q&A breakout session will be available approximately twenty-four hours after the Q&A breakout session ends and can be accessed at the same location for 90 days. [uthr-g]

About United Therapeutics

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-present-at-33rd-annual-jp-morgan-healthcare-conference-300016991.html

SOURCE United Therapeutics Corporation